Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that skin and nail changes can indicate various underlying health conditions.

Hair growth dysfunction involves various conditions with limited treatment options.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Reversing female hair loss.

A woman lost her hair after taking acyclovir, but it grew back when she stopped the medication.

A woman developed thick gums from everolimus treatment after a kidney transplant.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Sertraline, an antidepressant, may rarely cause hair loss.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Ruxolitinib can cause a delayed skin reaction on the nose.

The document concludes that understanding tissue degeneration is crucial for diagnosing skin lesions.

The medication lopinavir-ritonavir may cause severe hair loss.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Imiquimod cream can rarely cause temporary hair loss.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.